Home/Filings/4/0001104659-21-093983
4//SEC Filing

Raphael Erez 4

Accession 0001104659-21-093983

CIK 0001533998other

Filed

Jul 19, 8:00 PM ET

Accepted

Jul 20, 4:31 PM ET

Size

5.9 KB

Accession

0001104659-21-093983

Insider Transaction Report

Form 4
Period: 2021-07-18
Raphael Erez
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2021-07-18+688943,987 total
Holdings
  • Common Stock

    (indirect: By Dicilyon Consulting and Investment Ltd.)
    37,876
Footnotes (2)
  • [F1]The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2021.
  • [F2]The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Issuer

DarioHealth Corp.

CIK 0001533998

Entity typeother

Related Parties

1
  • filerCIK 0001668046

Filing Metadata

Form type
4
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:31 PM ET
Size
5.9 KB